ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Ascendis Pharma, INC.

Official 2024 U.S. DOL Form 5500 summary for Ascendis Pharma, INC. (Ascendis Pharma 401(k) Plan · EIN 26-1969053 · PN 001): $37.89M net assets, 294 active participants, and $15.93 per $10,000 (15.93 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAscendis Pharma, INC.
Filing IdentifierAscendis Pharma 401(k) Plan · EIN 26-1969053 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$37.89M
Active Participants294
Direct Admin Fee Rate$15.93 per $10,000 (15.93 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderEmpower Retirement
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($2.47M, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI